Tag Archives: Solution

“Frotox” Replacing Botox As Amerca’s Go Anti-Aging Solution

Author Katie Carter Published April 25, 2021 Word count 297 Botox has been the world’s favorite noninvasive cosmetic procedure for decades. Known for its ability to take years off in a matter of weeks, Botox has remained unmatched until today. New cryotherapy technology is quickly replacing Botox. Frotox is picking up headlines for its ability… Read More »

BLiNQ Networks’ embedded EPC by AttoCore is the WISP’s solution of choice

Cambridge, UK, March 17th 2021 – BLiNQ Networks has repurposed the Evolved Packet Core (EPC) to support the deployment of Fixed Wireless Access (FWA) networks into rural not-spots in the US and around the world. BLiNQ has achieved this by embedding AttoCore’s AttoEPC software directly into the BLiNQ FW-300i base station. By embedding the EPC… Read More »

HUBER+SUHNER unveils industry first 90 GHz multicoax testing solution

With the automotive, semiconductor and mobile communication sectors increasingly developing applications that require the E-band spectrum range, HUBER+SUHNER has today announced its MXPM90 test solution for frequencies up to 90 GHz. Created in response to these industry demands; this product will allow manufacturers to test their components with even greater accuracy. As testing of PAM4/400G… Read More »

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More »

FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia

FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia Print this page PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted under the 505(b)(2) regulatory pathway, for Cocaine Hydrochloride (HCl) Nasal Solution 4% (40 mg/mL), the company’s… Read More »

Osia, a New Type of Implantable Hearing Solution by Cochlear, Secures FDA Clearance: Interview

Earlier this month, Cochlear received FDA clearance for the Osia 2 System, the first active osseointegrated steady-state implant (OSI). The Osia System represents a new type of bone conducting hearing solution that uses digital piezoelectric stimulation to transmit sound vibration directly to the inner ear. While present in other auditory equipment and some medical devices,… Read More »